{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:10:52Z","timestamp":1775459452889,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00428-019-02606-9","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:10:47Z","timestamp":1561468247000},"page":"625-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis"],"prefix":"10.1007","volume":"475","author":[{"given":"Essia","family":"Saiji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne Gumy","family":"Pause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lascombes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Cerato Biderbost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie Lin","family":"Marq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Berczy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-792X","authenticated-orcid":false,"given":"Anne-Laure","family":"Rougemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"2606_CR1","unstructured":"(2012 ) World Health Organization Classification of Tumors. Pathology and genetics. IARC Press, Lyon"},{"key":"2606_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/PAS.0b013e31817eec2b","volume":"33","author":"D Eefting","year":"2009","unstructured":"Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovee JV, Hogendoorn PC, Tc EBN (2009) Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol 33:50\u201357. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e31817eec2b","journal-title":"Am J Surg Pathol"},{"key":"2606_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/path.2913","volume":"224","author":"MF Amary","year":"2011","unstructured":"Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F, Pollock R, O'Donnell P, Grigoriadis A, Diss T, Eskandarpour M, Presneau N, Hogendoorn PC, Futreal A, Tirabosco R, Flanagan AM (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224:334\u2013343. \nhttps:\/\/doi.org\/10.1002\/path.2913","journal-title":"J Pathol"},{"key":"2606_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2559.2011.04010.x","volume":"60","author":"S Damato","year":"2012","unstructured":"Damato S, Alorjani M, Bonar F, McCarthy SW, Cannon SR, O'Donnell P, Tirabosco R, Amary MF, Flanagan AM (2012) IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas. Histopathology 60:363\u2013365. \nhttps:\/\/doi.org\/10.1111\/j.1365-2559.2011.04010.x","journal-title":"Histopathology"},{"key":"2606_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773. \nhttps:\/\/doi.org\/10.1056\/NEJMoa0808710","journal-title":"N Engl J Med"},{"key":"2606_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10014-012-0085-1","volume":"29","author":"M Arai","year":"2012","unstructured":"Arai M, Nobusawa S, Ikota H, Takemura S, Nakazato Y (2012) Frequent IDH1\/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma. Brain Tumor Pathol 29:201\u2013206. \nhttps:\/\/doi.org\/10.1007\/s10014-012-0085-1","journal-title":"Brain Tumor Pathol"},{"key":"2606_CR7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ng.1004","volume":"43","author":"TC Pansuriya","year":"2011","unstructured":"Pansuriya TC, van Eijk R, d'Adamo P, van Ruler MA, Kuijjer ML, Oosting J, Cleton-Jansen AM, van Oosterwijk JG, Verbeke SL, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom LG, Daugaard S, Godfraind C, Boon LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovee JV (2011) Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 43:1256\u20131261. \nhttps:\/\/doi.org\/10.1038\/ng.1004","journal-title":"Nat Genet"},{"key":"2606_CR8","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/ng.994","volume":"43","author":"MF Amary","year":"2011","unstructured":"Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43:1262\u20131265. \nhttps:\/\/doi.org\/10.1038\/ng.994","journal-title":"Nat Genet"},{"key":"2606_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-015-0079-z","volume":"8","author":"JM Foster","year":"2015","unstructured":"Foster JM, Oumie A, Togneri FS, Vasques FR, Hau D, Taylor M, Tinkler-Hundal E, Southward K, Medlow P, McGreeghan-Crosby K, Halfpenny I, McMullan DJ, Quirke P, Keating KE, Griffiths M, Spink KG, Brew F (2015) Cross-laboratory validation of the OncoScan(R) FFPE assay, a multiplex tool for whole genome tumour profiling. BMC Med Genet 8:5. \nhttps:\/\/doi.org\/10.1186\/s12920-015-0079-z","journal-title":"BMC Med Genet"},{"key":"2606_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4149\/neo_2014_046","volume":"61","author":"GW Herget","year":"2014","unstructured":"Herget GW, Strohm P, Rottenburger C, Kontny U, Krauss T, Bohm J, Sudkamp N, Uhl M (2014) Insights into enchondroma, enchondromatosis and the risk of secondary chondrosarcoma. Review of the literature with an emphasis on the clinical behaviour, radiology, malignant transformation and the follow up. Neoplasma 61:365\u2013378. \nhttps:\/\/doi.org\/10.4149\/neo_2014_046","journal-title":"Neoplasma"},{"key":"2606_CR11","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1073\/pnas.1424400112","volume":"112","author":"M Hirata","year":"2015","unstructured":"Hirata M, Sasaki M, Cairns RA, Inoue S, Puviindran V, Li WY, Snow BE, Jones LD, Wei Q, Sato S, Tang YJ, Nadesan P, Rockel J, Whetstone H, Poon R, Weng A, Gross S, Straley K, Gliser C, Xu Y, Wunder J, Mak TW, Alman BA (2015) Mutant IDH is sufficient to initiate enchondromatosis in mice. Proc Natl Acad Sci U S A 112:2829\u20132834. \nhttps:\/\/doi.org\/10.1073\/pnas.1424400112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2606_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/cas.12337","volume":"105","author":"K Moriya","year":"2014","unstructured":"Moriya K, Kaneko MK, Liu X, Hosaka M, Fujishima F, Sakuma J, Ogasawara S, Watanabe M, Sasahara Y, Kure S, Kato Y (2014) IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome. Cancer Sci 105:359\u2013362. \nhttps:\/\/doi.org\/10.1111\/cas.12337","journal-title":"Cancer Sci"},{"key":"2606_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/PAP.0b013e31827b654d","volume":"20","author":"FG Schaap","year":"2013","unstructured":"Schaap FG, French PJ, Bovee JV (2013) Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors. Adv Anat Pathol 20:32\u201338. \nhttps:\/\/doi.org\/10.1097\/PAP.0b013e31827b654d","journal-title":"Adv Anat Pathol"},{"key":"2606_CR14","doi-asserted-by":"publisher","first-page":"14832","DOI":"10.18632\/oncotarget.4024","volume":"6","author":"J Suijker","year":"2015","unstructured":"Suijker J, Baelde HJ, Roelofs H, Cleton-Jansen AM, Bovee JV (2015) The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo. Oncotarget 6:14832\u201314842. \nhttps:\/\/doi.org\/10.18632\/oncotarget.4024","journal-title":"Oncotarget"},{"key":"2606_CR15","doi-asserted-by":"publisher","first-page":"12505","DOI":"10.18632\/oncotarget.3723","volume":"6","author":"J Suijker","year":"2015","unstructured":"Suijker J, Oosting J, Koornneef A, Struys EA, Salomons GS, Schaap FG, Waaijer CJ, Wijers-Koster PM, Briaire-de Bruijn IH, Haazen L, Riester SM, Dudakovic A, Danen E, Cleton-Jansen AM, van Wijnen AJ, Bovee JV (2015) Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines. Oncotarget 6:12505\u201312519. \nhttps:\/\/doi.org\/10.18632\/oncotarget.3723","journal-title":"Oncotarget"},{"key":"2606_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13569-017-0074-6","volume":"7","author":"AHG Cleven","year":"2017","unstructured":"Cleven AHG, Suijker J, Agrogiannis G, Briaire-de Bruijn IH, Frizzell N, Hoekstra AS, Wijers-Koster PM, Cleton-Jansen AM, Bovee J (2017) IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas. Clin Sarcoma Res 7:8. \nhttps:\/\/doi.org\/10.1186\/s13569-017-0074-6","journal-title":"Clin Sarcoma Res"},{"key":"2606_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/JBM.S70716","volume":"7","author":"J Mondesir","year":"2016","unstructured":"Mondesir J, Willekens C, Touat M, de Botton S (2016) IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med 7:171\u2013180. \nhttps:\/\/doi.org\/10.2147\/JBM.S70716","journal-title":"J Blood Med"},{"key":"2606_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nrg906","volume":"3","author":"H Youssoufian","year":"2002","unstructured":"Youssoufian H, Pyeritz RE (2002) Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet 3:748\u2013758. \nhttps:\/\/doi.org\/10.1038\/nrg906","journal-title":"Nat Rev Genet"},{"key":"2606_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/34432","volume":"391","author":"A Hemminki","year":"1998","unstructured":"Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA (1998) A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184\u2013187. \nhttps:\/\/doi.org\/10.1038\/34432","journal-title":"Nature"},{"key":"2606_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2011.01.014","volume":"306","author":"JL Herrmann","year":"2011","unstructured":"Herrmann JL, Byekova Y, Elmets CA, Athar M (2011) Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers. Cancer Lett 306:1\u20139. \nhttps:\/\/doi.org\/10.1016\/j.canlet.2011.01.014","journal-title":"Cancer Lett"},{"key":"2606_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2676","volume":"9","author":"DB Shackelford","year":"2009","unstructured":"Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9:563\u2013575. \nhttps:\/\/doi.org\/10.1038\/nrc2676","journal-title":"Nat Rev Cancer"},{"key":"2606_CR22","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/hmg\/ddi139","volume":"14","author":"C Forcet","year":"2005","unstructured":"Forcet C, Etienne-Manneville S, Gaude H, Fournier L, Debilly S, Salmi M, Baas A, Olschwang S, Clevers H, Billaud M (2005) Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. Hum Mol Genet 14:1283\u20131292. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddi139","journal-title":"Hum Mol Genet"},{"key":"2606_CR23","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1073\/pnas.1309001110","volume":"110","author":"LP Lai","year":"2013","unstructured":"Lai LP, Lilley BN, Sanes JR, McMahon AP (2013) Lkb1\/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation. Proc Natl Acad Sci U S A 110:19450\u201319455. \nhttps:\/\/doi.org\/10.1073\/pnas.1309001110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2606_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng0197-87","volume":"15","author":"A Hemminki","year":"1997","unstructured":"Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, Knuutila S, Salovaara R, Bodmer W, Shibata D, de la Chapelle A, Aaltonen LA (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87\u201390. \nhttps:\/\/doi.org\/10.1038\/ng0197-87","journal-title":"Nat Genet"},{"key":"2606_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/sj.onc.1203227","volume":"19","author":"M Esteller","year":"2000","unstructured":"Esteller M, Avizienyte E, Corn PG, Lothe RA, Baylin SB, Aaltonen LA, Herman JG (2000) Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19:164\u2013168. \nhttps:\/\/doi.org\/10.1038\/sj.onc.1203227","journal-title":"Oncogene"},{"key":"2606_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","volume":"156","author":"F Supek","year":"2014","unstructured":"Supek F, Minana B, Valcarcel J, Gabaldon T, Lehner B (2014) Synonymous mutations frequently act as driver mutations in human cancers. Cell 156:1324\u20131335. \nhttps:\/\/doi.org\/10.1016\/j.cell.2014.01.051","journal-title":"Cell"},{"key":"2606_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","volume":"20","author":"D Capper","year":"2010","unstructured":"Capper D, Weissert S, Balss J, Habel A, Meyer J, Jager D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245\u2013254. \nhttps:\/\/doi.org\/10.1111\/j.1750-3639.2009.00352.x","journal-title":"Brain Pathol"},{"key":"2606_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/PAS.0000000000000325","volume":"39","author":"KJ Jabbar","year":"2015","unstructured":"Jabbar KJ, Luthra R, Patel KP, Singh RR, Goswami R, Aldape KD, Medeiros LJ, Routbort MJ (2015) Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry. Am J Surg Pathol 39:454\u2013461. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000325","journal-title":"Am J Surg Pathol"},{"key":"2606_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/NEN.0b013e31822713f0","volume":"70","author":"M Preusser","year":"2011","unstructured":"Preusser M, Wohrer A, Stary S, Hoftberger R, Streubel B, Hainfellner JA (2011) Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens. J Neuropathol Exp Neurol 70:715\u2013723. \nhttps:\/\/doi.org\/10.1097\/NEN.0b013e31822713f0","journal-title":"J Neuropathol Exp Neurol"},{"key":"2606_CR30","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/neuonc\/not015","volume":"15","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Sharma MC, Jha P, Pathak P, Suri V, Sarkar C, Chosdol K, Suri A, Kale SS, Mahapatra AK (2013) Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing. Neuro-Oncology 15:718\u2013726. \nhttps:\/\/doi.org\/10.1093\/neuonc\/not015","journal-title":"Neuro-Oncology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02606-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02606-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02606-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:17:38Z","timestamp":1592954258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02606-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2606"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02606-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors\/coauthors declare that the study has complied with the ethical standards. This study was approved by the Commission Cantonale d\u2019Ethique de la Recherche (CCER Review Board, approval number GE 14-229).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}